Ethypharm is a leading mid-size international specialty pharmaceutical company, with strong European roots, that manufactures and provides essential medicines with a focus on Central Nervous System (severe pain and addiction) and Hospital Injectables.
Discover Ethypharm at a glance
At Ethypharm, our mission is to improve patients’ lives by providing essential medicines and making a positive impact on society and the environment.
Our products are treating:
– Severe pain
– Addiction
– Critical care situations
Ethypharm is deeply engaged in the Central Nervous System and Hospital Injectable areas, where our medicines treat patients and our teams work on innovative solutions for tomorrow. Willing to grow beyond our recognised positions in the treatment of severe pain and addiction, we are constantly screening opportunities in search for those which will respond to unmet needs in our two core areas.
Ethypharm is a rapidly evolving company with a clear strategy and significant growth ambitions.
Through strategic geographical expansions and commercial team committed to achieving great results, we’re dedicated to connecting with customers and making a meaningful impact in patients’lives in every market we enter.
We are open to discussing potential partnerships.
Get to know our business development (BD) teams and come discuss with us!
Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director
Saint-Cloud (France), Friday 4 October 2024 – Denis DELVAL, President & CEO of the Ethypharm Group, announces the appointment of Éric CHEVALIER as Group Human Resources Director with effect from 1 October 2024.
Read moreEthypharm will be exhibiting at CPHI Europe in Milan from 8 to 10th October 2024!
Ethypharm is excited to announce its participation in CPHI Europe 2024, taking place in Milan from October 8 to 10, 2024. We invite you to visit us in Hall 7, Stand 7G84. CPHI Europe is a key event in the international pharmaceutical industry, offering a platform to grow business and engage meaningful connections with our […]
Read more